Renovaro Inc (RENB) Live Share Price, Invest From India

Renovaro Inc Stock Performance

as on October 1, 2025 at 1:29 am IST

Day's Low
Day's High
$1.13
Day's Price Range
$1.43
$1.41
19.86%
Downside
1.42%
Upside
52 Week's Low
52 Week's High
$0.12
52-Week Price Range
$2.1
$1.41
91.39%
Downside
48.94%
Upside

Renovaro Inc share price movements today

Previous Close: $1.27
Open: $1.24
Volume: 905.0K
Day's Low - High: $1.13 - $1.43
52 Week Low - High: $0.12 - $2.1

Renovaro Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Renovaro Inc Stock Fundamentals & Key Indicators

Check Renovaro Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Renovaro Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Renovaro Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Renovaro Inc	NA	$-	NA	NA	0.00%
Beone Medicines Ltd	NA	$35.8B	NA	NA	-3.89%
Alnylam Pharmaceuticals, Inc.	BUY	$60.7B	283.23%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$108.0B	101.68%	29.95	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	3.22%	14.55	31.37%

Renovaro Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	-	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	-	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-4	-23	-9	-4	-58	-17	-44	-7	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-24365.42%	0.00%	0.00%

Renovaro Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Total Revenue	0	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-1	-2	-6	-18	-11	-26	-113	-39	-80
Net Profit Margin	-4057.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Renovaro Inc

Funds	Holdings
Vanguard Group Inc	2.13%
BlackRock Inc	1.17%
Millennium Management LLC	0.93%
Geode Capital Management, LLC	0.44%
Jane Street Group LLC	0.39%

See all

Insights on Renovaro Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 134.6%
NO EFFECT
Against Peers
In the last 3 years, Beone Medicines Ltd has given 123.6% return, outperforming this stock by 216.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RENB stock has moved down by -26.7%

About Renovaro Inc

Lunai Bioworks, Inc., formerly Renovaro Inc., is focused on AI-powered biodefense, drug discovery and advanced diagnostics. The Company is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform. These are designed to transform clinical decision-making, reduce time-to-treatment, and unlock previously inaccessible insights from biological data. Its proprietary platforms in translational analytics, in vivo modeling, and machine vision-accelerating biomarker discovery and therapeutic development in precision neurology and infectious disease.

Organisation	Renovaro Inc
E-voting on shares	Click here to vote

FAQs

What is Renovaro Inc share price today?

Renovaro Inc share price today is $1.41 as on October 1, 2025 at 1:29 am IST at the close of the market. Renovaro Inc share today touched a day high of $1.43 and a low of $1.13.

What is the 52 week high and 52 week low for Renovaro Inc share?

Renovaro Inc share touched a 52 week high of $2.1 on December 9, 2024 and a 52 week low of $0.12 on September 29, 2025. Renovaro Inc stock price today i.e. October 1, 2025 at 1:29 am IST is closed at $1.41,which is 32.86% down from its 52 week high and 1061.45% up from its 52 week low.

How to invest in Renovaro Inc Stock (RENB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Renovaro Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Renovaro Inc Shares that will get you 1.0638 shares as per Renovaro Inc share price of $1.41 per share as on October 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Renovaro Inc Stock (RENB) from India?

Indian investors can start investing in Renovaro Inc (RENB) shares with as little as ₹88.237 or $1 (as of October 28, 2025 at 6:01 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.37 in Renovaro Inc stock (as per the Rupee-Dollar exchange rate as on October 28, 2025 at 6:01 pm IST). Based on Renovaro Inc share’s latest price of $1.41 as on October 1, 2025 at 1:29 am IST, you will get 7.0922 shares of Renovaro Inc. Learn more about fractional shares .

Renovaro Inc Share Price